杂交冠状动脉血运重建技术治疗冠状动脉粥样硬化性心脏病研究进展

doi:10.3969/j.issn.1006-5725.2025.06.022

Abstract

Abstract:

The incidence rate of coronary atherosclerotic heart disease （commonly referred to as coronary heart disease） remains high in China. In clinical practice， drug therapy， percutaneous coronary intervention （PCI）， and coronary artery bypass grafting （CABG） are commonly employed. For patients with multi?vessel coronary artery stenosis， minimally invasive interventional therapy is often the preferred option. However， for those with multi?vessel disease complicated by comorbidities， CABG is generally recommended. Despite its advantages， PCI carries risks such as vascular restenosis， thrombosis， and other adverse events. Consequently， hybrid coronary revascularization （HCR） has emerged as an alternative approach. This paper provides an overview of coronary heart disease and reviews the advantages， applications， and patient selection criteria for HCR.

Key words: hybrid coronary revascularization, coronary atherosclerotic heart disease, percutaneous coronary intervention, coronary artery bypass grafting, progress

CLC Number:

R654.2

Xiaoyu ZHANG,Yuanyuan PAN,Minghuan FU,Yun LIN,Yiran CHEN,Yu. PENG. Research progress of hybrid coronary revascularization in treating coronary atherosclerotic heart disease[J]. The Journal of Practical Medicine, 2025, 41(6): 916-920.

References 35

1	龙珊，刘兴德，李甜甜，等. 冠心病患者经皮冠状动脉介入治疗术后合并焦虑抑郁机制及治疗的研究进展［J］. 实用医学杂志， 2023， 39（21）：2850-2856. doi:10.3969/j.issn.1006-5725.2023.21.026 doi: 10.3969/j.issn.1006-5725.2023.21.026
2	CUI M， LI F， GANG X， et al. Association Of Alcohol Consumption With All‐Cause Mortality， New‐Onset Stroke， And Coronary Heart Disease In Patients With Abnormal Glucose Metabolism—Findings From a 10‐Year Follow‐Up Of The Reaction Study［J］. J Diabetes， 2023， 15：289-298. doi:10.1111/1753-0407.13371 doi: 10.1111/1753-0407.13371
3	赵子明，马琪，陈俭，等. 司美格鲁肽注射液对不稳定型心绞痛合并糖尿病患者冠脉介入术预后的影响［J］. 实用医学杂志， 2024， 40（24）：3515-3520.
4	李慧君，李文龙，吴辉，等. 河南省新乡县成年农村居民冠心病患病现状及其影响因素分析［J］. 中国公共卫生， 2022， 38（7）：861-865.
5	张文静，郭菲菲，王志浩，等. 自我调节疲劳在老年冠心病行PCI术治疗患者心理困扰与积极度间的中介作用［J］. 中华老年医学杂志， 2024， 43（8）：1025-1029.
6	王旭杰，张菀桐，郭明冬，等. 国医大师翁维良教授治疗高龄老年冠心病经验［J］. 中华中医药学刊， 2023， 41（5）：124-127.
7	ZHAO Z， LI L， GAO X， et al. High dietary inflammatory index is associated with decreased plaque stability in patients with coronary heart disease［J］. Nutr Res， 2023， 119：56-64. doi:10.1016/j.nutres.2023.08.007 doi: 10.1016/j.nutres.2023.08.007
8	ZHANG P， LIANG T， WANG X，et al. Serum-Derived Exosomes from Patients with Coronary Artery Disease Induce Endothelial Injury and Inflammation in Human Umbilical Vein Endothelial Cells［J］. Int Heart J， 2021， 62（2）：396-406. doi:10.1536/ihj.20-641 doi: 10.1536/ihj.20-641
9	CHASOVSKIKH N Y， SHESTAKOVA E E. Analysis of the Involvement of Susceptibility Genes to Coronary Heart Disease in Implementation Signaling and Metabolic Pathways［J］. Russian J Genet， 2024， 60（4）：524-532. doi:10.1134/s1022795424040045 doi: 10.1134/s1022795424040045
10	KALASKA B， MIKLOSZ J， SWIETON J， et al. The effect of ChAdOx1 nCov-19 vaccine on arterial thrombosis development and platelet aggregation in female rats［J］. Vaccine， 2022， 40（13）：1996-2002. doi:10.1016/j.vaccine.2022.02.037 doi: 10.1016/j.vaccine.2022.02.037
11	韩慧莹，刘寨华，张华敏，等. 基于“因郁致病”“因病致郁”探讨冠心病与抑郁症的共病机理［J］. 中医杂志， 2024， 65（8）：858-861.
12	张小波，李大鹤，赵园园，等. 高龄男性冠心病患者血清睾酮与同型半胱氨酸水平的相关性［J］. 中国老年学杂志， 2022，42（12）：2857-2859.
13	陈茗莉，郑群，马芳芳，等. 4种血清因子预测冠状动脉粥样硬化性心脏病发病的价值［J］. 中华高血压杂志， 2022， 30（11）：1080-1084.
14	ERDMANN E. Coronary Heart Disease： Advances in Diagnostics and Therapy［J］. Dtsch Med Wochenschr，2017，142（21）：1565-1566. doi:10.1055/s-0042-112806 doi: 10.1055/s-0042-112806
15	KANDASWAMY E， ZUO L. Recent advances in treatment of coronary artery disease： role of science and technology［J］. Int J Mol Sci，2018，19（2）：424-425. doi:10.3390/ijms19020424 doi: 10.3390/ijms19020424
16	DOENST T， HAVERICH A， SERRUYS P，et al. PCI and CABG for treating stable coronary artery disease： Jacc review topic of the week［J］. J Am Coll Cardiol，2019，73（8）：964-976. doi:10.1016/j.jacc.2018.11.053 doi: 10.1016/j.jacc.2018.11.053
17	THUIJS D J， KAPPETEIN A P， SERRUYS P W， et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease： 10-year follow-up of the multicentrerandomised controlled SYNTAX trial［J］. Lancet，2019，394（10206）：1325-1334.
18	SHAEFI S， MITTEL A， LOBERMAN D， et al. Off-Pump Versus On-Pump Coronary Artery Bypass Grafting-A Systematic Review and Analysis of Clinical Outcomes［J］. J Cardiothorac Vasc Anesth， 2019，33（1）：232-244. doi:10.1053/j.jvca.2018.04.012 doi: 10.1053/j.jvca.2018.04.012
19	WEATHERB Y L. Coronary artery bypass grafting： A clinical overview［J］. Crit Care Nurs Q，2018，41（4）：356-359. doi:10.1097/cnq.0000000000000220 doi: 10.1097/cnq.0000000000000220
20	张召，耳建旭，翟文倩，等. 乌司他丁对非体外循环冠状动脉旁路移植术患者术后肺部并发症的影响［J］. 中华麻醉学杂志， 2024， 44（3）：260-266.
21	NIV A D. Blood Transfusion， Coronary Bypass Grafting Surgery and Late Survival： An Impossible Task Done Well［J］. Ann thoracic surg， 2022， 115（3）：769-770. doi:10.1016/j.athoracsur.2022.12.002 doi: 10.1016/j.athoracsur.2022.12.002
22	张继倬，韩露，陈兴华，等. 70 岁及以上老年患者体外循环与非体外循环冠状动脉旁路移植术的对比研究［J］. 中国全科医学， 2014， 17（7）： 2033-2035，2039.
23	MATTHIAS T， NIKOLAOS B， EMANUELE B， et al. Hybrid coronary revascularization： Position paper of the European Society of Cardiology Working Group on Cardiovascular Surgery and European Association of Percutaneous Cardiovascular Interventions［J］. Eur J Cardiothorac Srug， 2024， 66（2）：271. doi:10.1093/ejcts/ezae271 doi: 10.1093/ejcts/ezae271
24	ZHU P， ZHOU P， SUN Y， et al. Hybrid coronary revascularization versus coronary artery bypass grafting for multivessel coronary artery disease： Systematic review and meta-analysis ［J］. J Cardiothorac Surg， 2015， 10263. doi:10.1186/s13019-015-0262-5 doi: 10.1186/s13019-015-0262-5
25	SAYEDAHMAD Z， DARMOCH F， PACHA H M，et al. Hybrid Coronary Revascularization Versus Coronary Artery Bypass Graft In Patients With Multivessel Coronary Artery Disease： A Meta-Analysis［J］. J Am Coll Cardiol， 2020， 75（11）：1145. doi:10.1016/s0735-1097(20)31772-1 doi: 10.1016/s0735-1097(20)31772-1
26	胡盛寿，高润霖，杨跃进，等. 中国冠状动脉血运重建适宜性标准的建议（试行）［J］. 中国循环杂志， 2016， 31（4）：313-317.
27	刘子腾，吴瑞锋，杨炜琦，等. 杂交冠状动脉血运重建术在冠心病治疗中的应用价值［J］. 河北医科大学学报， 2019， 40（6）：667-670.
28	KARI L D， UMME A， ETTORINO T D， et al. Hybrid coronary revascularization versus coronary artery bypass grafting for multivessel coronary artery disease： A systematic review and meta-analysis［J］. Int J Cardiol， 2022， 35920-35927.
29	IACONA G M， BAKHOS J J， TONG M Z， et al. Coronary artery bypass grafting in left ventricular dysfunction： when and how［J］.Curr Opin Cardiol， 2023， 38（6）：464-470. doi:10.1097/hco.0000000000001090 doi: 10.1097/hco.0000000000001090
30	ANDREAS T， STEFANOS G， FOTIS K， et al. C-8 \| Hybrid Coronary Revascularization （HCR） vs. Coronary Artery Bypass Grafting （CABG） in Multivessel Coronary Artery Disease （MVCAD）： A Meta-analysis of 14 Studies Comprising 4，226 Patients［J］. J Society Cardio Angiog Int， 2022， 1（3）：100160. doi:10.1016/j.jscai.2022.100160 doi: 10.1016/j.jscai.2022.100160
31	GAO C， HE X， LIU Y， et al. Drug-coated balloon angioplasty with provisional stenting versus primary stenting for the treatment of de novo coronary artery lesions： REC-CAGEFREE I trial rationale and design［J］. BMC Cardiovasc Disord， 2024， 24（1）：51-54. doi:10.1186/s12872-024-03974-0 doi: 10.1186/s12872-024-03974-0
32	生伟，邢聪慧，牛兆倬，等. “一站式”杂交技术在冠状动脉多支血管病变中的临床应用［J］. 中国胸心血管外科临床杂志， 2020， 27（11）：1367-1370.
33	ODA R， KAJIMOTO K， YAMAMOTO T， et al. Long-Term Outcomes of Coronary Artery Bypass Grafting Using an Internal Thoracic Artery versus a Radial Artery as a Second Arterial Graft［J］.Ann Thoracic Cardiovas， 2024， 30（1）：29-34. doi:10.5761/atcs.oa.24-00029 doi: 10.5761/atcs.oa.24-00029
34	刘硕，尤斌，陈长城，等. 微创冠状动脉杂交在冠状动脉多支病变中的临床应用［J］. 心肺血管病杂志， 2019， 38（7）：736-740.
35	安涛，侯志辉，杨研，等. 对比抗血小板与抗凝治疗对心脏瓣膜置换同期行冠状动脉旁路移植术后桥血管通畅情况的影响［J］. 中国循证心血管医学杂志， 2020， 12（1）：87-90.

[1]	Shengbo LI,Ling FENG,Beibei CHEN,Fang YAO,Yongsheng XING,Yanbin. LIU. Effect of intra⁃aortic balloon counterpulsation combined with rhBNP on ventricular remodeling in elderly patients with acute anterior myocardial infarction before emergency PCI [J]. The Journal of Practical Medicine, 2025, 41(5): 699-703.
[2]	Guangyan WANG,Heng SU,Jun. ZHU. Effect of dagliflozin combined with levosimendan on sST2， Ang⁃Ⅱ and cardiac function in elderly patients with post⁃PCI heart failure [J]. The Journal of Practical Medicine, 2025, 41(3): 396-402.
[3]	Yanyan JIA,Yijia SUN,Di ZHAO,Yan. SONG. Elderly acute progressive cerebral infarction patients′ serum PLA2， called S100B levels and the relationship between carotid plaques [J]. The Journal of Practical Medicine, 2025, 41(2): 244-249.
[4]	Shifang YANG,Xinglin GAO,Jing LI,Lupeng. JI. Sarcopenia associated with chronic obstructive pulmonary disease [J]. The Journal of Practical Medicine, 2024, 40(9): 1181-1185.
[5]	Yue REN,Ting TIAN,Guangsheng WEI,Ming ZHANG,Hong YU,Jie LI,Tingting DONG,Yinmei FENG,Hongchao CUI,Jiao. ZHANG. Effect of stage I comprehensive cardiac rehabilitation in patients with acute ST elevation myocardial infarctionafter emergency percutaneous coronary intervention [J]. The Journal of Practical Medicine, 2024, 40(5): 682-687.
[6]	Jianlong SHENG,Ni′na. LIU. The advanced progress on the relationship between hyperuricemia and acute myocardial infarction [J]. The Journal of Practical Medicine, 2024, 40(5): 727-730.
[7]	Shan GAO,Kun JI,Li ZHAO,Yujia XING,Yandong XIE,Xiqiang CAI. Research progress on esophageal squamous intraepithelial neoplasia [J]. The Journal of Practical Medicine, 2024, 40(3): 432-438.
[8]	Ziming ZHAO,Qi MA,Jian CHEN,Yuan CHEN,Liuyi CUI,Yujie. ZHAO. Effects of semaglutide on prognosis in patients with diabetes mellitus complicated with unstable angina after percutaneous coronary intervention [J]. The Journal of Practical Medicine, 2024, 40(24): 3515-3520.
[9]	Minghua LUO,Yushan CHEN,He WANG,Huaimin GUAN,Jinhong. XIE. Effect of different methods of hemodynamic support for patients with cardiac shock complicating acute myocardial infarctionduring percutaneous coronary intervention process [J]. The Journal of Practical Medicine, 2024, 40(23): 3317-3322.
[10]	Jie LI,Nian DENG,Guofeng SHI,Tao XU,Li YANG,Yu ZHANG,Yueyue SONG,Yuanzhu LIAO,Yixia. ZHOU. Impacts of cognitive behavioral therapy based on 5G internet of things on rehabilitation and kinesiophobia in elderly patients with coronary artery diseasefollowing PCI [J]. The Journal of Practical Medicine, 2024, 40(23): 3384-3388.
[11]	Xiao XIAO,Fangyi LONG,Gang. WANG. Dual role and new strategies of pyroptosis in cancer therapy [J]. The Journal of Practical Medicine, 2024, 40(23): 3419-3426.
[12]	Qian ZHAO,Yan ZHANG,Qiao QIAO,Aiyun DENG. Prognostic factors of patients undergoing percutaneous coronary intervention supported by extracorporeal membrane oxygenation [J]. The Journal of Practical Medicine, 2024, 40(2): 219-224.
[13]	Shuping GE,Wei CHEN,Xinxin JIA,Min GAO,Min HE,Cunyu. QIN. Effect of individual exercise training as the core cardiac rehabilitation program on the rehabilitation of patients with coronary heart disease after percutaneous coronary intervention [J]. The Journal of Practical Medicine, 2024, 40(18): 2607-2611.
[14]	Ganggang LU,Shenglong LI,Yongqiang ZHAO,Yunpeng JIA,Yonglin LIANG,Yuanbo. ZHAO. Research progress on the correlation between oxidative stress and ferroptosis in diabetic impotence [J]. The Journal of Practical Medicine, 2024, 40(16): 2229-2235.
[15]	Xin DOU,Changhui HE,Xiao MEI,Haidi PAN,Yuanxin MA,Wei. WANG. Research progress on the intervention of traditional Chinese medicine in IBS⁃D based on the "SCFAs⁃intestinal barrier" pathway [J]. The Journal of Practical Medicine, 2024, 40(15): 2177-2182.

Research progress of hybrid coronary revascularization in treating coronary atherosclerotic heart disease

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 35

Related Articles 15

Recommended Articles

Metrics

Comments